Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANVS
#4205
Annovis Bio, Inc. Common Stock
1.0
4
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.89%
Monthly Change
-7.14%
6 month change
-40.91%
Year Change
-36.59%
Previous Close
1.0
6
Open
1.0
7
Low
1.0
1
High
1.0
7
Markets
US Stock Market
Healthcare
Biotechnology
ANVS
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2020
Quarterly report, Q2 FY2020
2020.07.29
Annovis Bio, Inc. quarterly report, Q2 FY2020
10-Q
Quarterly report, Q1 FY2020
2020.05.05
Annovis Bio, Inc. quarterly report, Q1 FY2020
10-Q
2019
Annual report, Q4 FY2019
2020.03.25
Annovis Bio, Inc. annual report, Q4 FY2019
10-K
1
2
3
4
5
6
7
News
Annovis Bio (ANVS) Loses 26.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Annovis Bio to launch long-term Parkinson’s drug study in January
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops
Annovis Bio director Hoffman buys $193,794 in shares
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling
Annovis Bio director Hoffman buys $69.9k in ANVS stock
Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)
Annovis Bio’s phase 3 Alzheimer’s trial reaches 25% completion
Annovis Bio raises $3.4 million in registered direct offering
Annovis Bio raises $6 million in registered direct offering
Annovis Bio reports buntanetap reduces inflammation in Alzheimer’s patients